Due to the complex physiological structure, microenvironment and multiple physiological
barriers, traditional anti‐cancer drugs are severely restricted from reaching the tumour site …

Nanotechnology has opened up a world of possibilities for the treatment of brain disorders.
Nanosystems can be designed to encapsulate, carry, and deliver a variety of therapeutic …

Central nervous system (CNS) diseases are among the most difficult to treat, mainly
because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach …

Peptides have gained more and more interest as therapeutics for different fields of medical
indications. Built up via a peptide bond from naturally occurring amino acids they stand out …

Peptide nanoassemblies have garnered remarkable importance in the development of novel
nanoscale biomaterials for drug delivery into tumor cells. Taking advantage of receptor …

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer,
and is among the most aggressive and still incurable cancers. Innovative and successful …

Cancer is a collection of diseases caused by specific changes at the genomic level that
support cell proliferation indefinitely. Traditionally, ion channels are known to control a …

After nearly 50 years of research and development, peptide therapeutics have dramatically
evolved from rather simple chemical structures (oftentimes linear and relatively short …

Targeting Specific Barriers | SpringerLink Skip to main content Advertisement SpringerLink
Account Menu Find a journal Publish with us Track your research Search Cart Book cover …